In vivo blunt-end cloning through CRISPR/Cas9-facilitated non-homologous end-joining
about
Next-generation mammalian genetics toward organism-level systems biologyImmunogenomic engineering of a plug-and-(dis)play hybridoma platform.UAP56 is a conserved crucial component of a divergent mRNA export pathway in Toxoplasma gondiiEfficient CRISPR/Cas9-Mediated Versatile, Predictable, and Donor-Free Gene Knockout in Human Pluripotent Stem CellsThe expanding footprint of CRISPR/Cas9 in the plant sciences.Use of genome-editing tools to treat sickle cell disease.Genome Editing Techniques and Their Therapeutic Applications.Rapidly inducible Cas9 and DSB-ddPCR to probe editing kinetics.A Multipurpose Toolkit to Enable Advanced Genome Engineering in Plants.Practical method for targeted disruption of cilia-related genes by using CRISPR/Cas9-mediated, homology-independent knock-in system.In vivo genome editing via the HITI method as a tool for gene therapy.Gene Editing and Crop Improvement Using CRISPR-Cas9 System.A convenient method to pre-screen candidate guide RNAs for CRISPR/Cas9 gene editing by NHEJ-mediated integration of a 'self-cleaving' GFP-expression plasmid.Repair of a Site-Specific DNA Cleavage: Old-School Lessons for Cas9-Mediated Gene Editing.Mutational signatures of non-homologous and polymerase theta-mediated end-joining in embryonic stem cells.Applications of Alternative Nucleases in the Age of CRISPR/Cas9.CRISPR/Cas9 cleavages in budding yeast reveal templated insertions and strand-specific insertion/deletion profiles.CRISPR: From Prokaryotic Immune Systems to Plant Genome Editing Tools.Kinetics and Fidelity of the Repair of Cas9-Induced Double-Strand DNA Breaks.Introduction of Large Sequence Inserts by CRISPR-Cas9 To Create Pathogenicity Mutants in the Multinucleate Filamentous Pathogen Sclerotinia sclerotiorum.
P2860
Q33765741-1C2069A8-0C9C-48A3-83E0-1F5127A770C8Q34047293-E60016DD-1F6A-43B3-B023-4A9231DD72D4Q36108196-9E96E074-5E70-46AD-98FD-A64CE20B5776Q37274503-DF658BC8-4FF8-41D5-B498-12379F7B92C7Q38823331-C1401C34-3153-4FD6-B7BD-80F91E558B15Q38850483-1D2B102C-B04D-4DFC-BF80-2C06B0DB4260Q38991325-FA14A445-CA42-4E3C-AEC2-98B5D234595BQ40489156-8355C698-3DA3-455E-A749-52AF52769FD7Q41358737-44DEBCFD-AAD5-4FA4-A45F-0A810AF1C7EBQ42292411-79C55CEE-4AA1-4BDA-8D1F-349204B9E8F6Q45875550-770F2C9C-84EF-4690-8667-1E79A5B429B2Q46170048-53D11938-6FA1-41AA-BDDA-945B615948F8Q46340316-C9495519-2EE4-4BBA-A6D7-7F335AAB2FDAQ47230819-D6745D35-7C39-40E0-B468-56227D43BAC8Q47254698-162E0F58-F028-4734-AC18-ADC619A2DEF8Q47352665-06E81FD2-637A-4D2A-99FD-A1B677A6130DQ50026209-5CB50CBB-99E0-497C-9133-E3B706A91B16Q50053332-CEBED97E-7AB4-4F16-8443-E96D01402C01Q55088632-6C96BEB5-0689-4238-8FCA-85750F9051BFQ55367646-14BE20E4-041F-4E5F-A18D-348CA7D3EABE
P2860
In vivo blunt-end cloning through CRISPR/Cas9-facilitated non-homologous end-joining
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
In vivo blunt-end cloning through CRISPR/Cas9-facilitated non-homologous end-joining
@en
type
label
In vivo blunt-end cloning through CRISPR/Cas9-facilitated non-homologous end-joining
@en
prefLabel
In vivo blunt-end cloning through CRISPR/Cas9-facilitated non-homologous end-joining
@en
P2093
P2860
P356
P1476
In vivo blunt-end cloning through CRISPR/Cas9-facilitated non-homologous end-joining
@en
P2093
Jonathan M Geisinger
Laura P Spector
Michele P Calos
Sophia Hernandez
Sören Turan
P2860
P356
10.1093/NAR/GKV1542
P407
P577
2016-01-13T00:00:00Z